ATE481983T1 - Frpb proteinmutante und verfahren zur erneuten faltung - Google Patents

Frpb proteinmutante und verfahren zur erneuten faltung

Info

Publication number
ATE481983T1
ATE481983T1 AT03779785T AT03779785T ATE481983T1 AT E481983 T1 ATE481983 T1 AT E481983T1 AT 03779785 T AT03779785 T AT 03779785T AT 03779785 T AT03779785 T AT 03779785T AT E481983 T1 ATE481983 T1 AT E481983T1
Authority
AT
Austria
Prior art keywords
frpb protein
protein mutant
refolding method
frpb
refolding
Prior art date
Application number
AT03779785T
Other languages
German (de)
English (en)
Inventor
Ralph Biemans
Philippe Denoel
Christiane Feron
Carine Goraj
Jeroen Kortekaas
Jan Poolman
Jan Tommassen
Vincent Weynants
Original Assignee
Glaxosmithkline Biolog Sa
Univ Utrecht
Technology Foundation Stichtin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa, Univ Utrecht, Technology Foundation Stichtin filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE481983T1 publication Critical patent/ATE481983T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045Moraxella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AT03779785T 2002-08-30 2003-08-28 Frpb proteinmutante und verfahren zur erneuten faltung ATE481983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0220199.4A GB0220199D0 (en) 2002-08-30 2002-08-30 Mutant protein and refolding method
PCT/EP2003/009634 WO2004020463A2 (en) 2002-08-30 2003-08-28 Mutant protein and refolding method

Publications (1)

Publication Number Publication Date
ATE481983T1 true ATE481983T1 (de) 2010-10-15

Family

ID=9943242

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03779785T ATE481983T1 (de) 2002-08-30 2003-08-28 Frpb proteinmutante und verfahren zur erneuten faltung

Country Status (10)

Country Link
US (1) US20060141563A1 (OSRAM)
EP (1) EP1572729B1 (OSRAM)
JP (1) JP2006516183A (OSRAM)
AT (1) ATE481983T1 (OSRAM)
AU (1) AU2003287945A1 (OSRAM)
CA (1) CA2495086A1 (OSRAM)
DE (1) DE60334316D1 (OSRAM)
ES (1) ES2351598T3 (OSRAM)
GB (1) GB0220199D0 (OSRAM)
WO (1) WO2004020463A2 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2414667A (en) 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
KR101359953B1 (ko) * 2005-06-27 2014-02-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
US20090123499A1 (en) * 2006-06-12 2009-05-14 Nathalie Devos Vaccine
EP2382985B1 (en) * 2008-12-25 2015-05-06 The Chemo-Sero-Therapeutic Research Institute Recombinant avian-infectious coryza vaccine and method for producing same
BR112013005626B1 (pt) * 2010-09-10 2022-07-26 Glaxosmithkline Biologicals Sa Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
ES2529442T3 (es) * 2010-09-28 2015-02-20 Abera Bioscience Ab Proteína de fusión para la expresión de proteínas secretoras

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
JP4019432B2 (ja) * 1995-12-21 2007-12-12 味の素株式会社 ヒトアクチビンaのリフォールディング方法
ES2389719T3 (es) * 2000-01-25 2012-10-30 The University Of Queensland Proteínas que comprenden regiones conservadas del antígeno de superficie de Neisseria meningitidis NhhA

Also Published As

Publication number Publication date
EP1572729B1 (en) 2010-09-22
WO2004020463A3 (en) 2005-08-18
EP1572729A2 (en) 2005-09-14
GB0220199D0 (en) 2002-10-09
WO2004020463A2 (en) 2004-03-11
AU2003287945A1 (en) 2004-03-19
AU2003287945A8 (en) 2004-03-19
DE60334316D1 (de) 2010-11-04
JP2006516183A (ja) 2006-06-29
US20060141563A1 (en) 2006-06-29
CA2495086A1 (en) 2004-03-11
ES2351598T3 (es) 2011-02-08

Similar Documents

Publication Publication Date Title
ATE450619T1 (de) Defructosylierungsverfahren
DE602004023229D1 (de) Mais metallothionen promoter 2 und methoden zur verwendung
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
DE60207053D1 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
ATE484201T1 (de) Verwendung von beta-cryptoxanthin
ATE492631T1 (de) Verwendung von mutationen zur verbesserung von aspergillus-phytasen
ATE481983T1 (de) Frpb proteinmutante und verfahren zur erneuten faltung
DE602005026855D1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
ATE323763T1 (de) Dna & protein bindende miniatur proteine
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
NO20050599L (no) Fremgangsmate for a anrike og spore patologisk modifiserte prion-proteiner (PRPsc)
DE60336205D1 (de) Verfahren zur Betriebsmodusnotifizierung.
ATE370964T1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
ATE392480T1 (de) Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
DE60326446D1 (de) Zusammensetzungen auf basis von kieselsäure und protein-autolysate zur anlockung und bekämpfung von arthropoden
ATE269905T1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
ATE437650T1 (de) Tyrosinasemutante und verfahren zur verwendung davon
DE60317620D1 (de) Methode zur Bestimmung von UDP-GlcNac
DE602006010990D1 (de) Verfahren zur dipeptidherstellung
BRPI0408023A (pt) métodos para previnir gliconoilação de proteìnas
DE50204038D1 (de) Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties